CymitQuimica logo
Apoptosi

Apoptosi

Gli inibitori dell'apoptosi sono composti che prevengono o ritardano il processo di morte cellulare programmata, noto come apoptosi. Questi inibitori sono fondamentali per lo studio dei meccanismi di sopravvivenza cellulare e vengono utilizzati per indagare sulle malattie in cui l'apoptosi è disregolata, come il cancro, i disturbi neurodegenerativi e le malattie autoimmuni. Modulando l'apoptosi, questi inibitori possono aiutare nello sviluppo di terapie mirate a controllare la morte cellulare. Presso CymitQuimica, offriamo una vasta selezione di inibitori dell'apoptosi di alta qualità per supportare le tue ricerche in biologia cellulare, oncologia e campi correlati.

Sottocategorie di "Apoptosi"

Mostrare 6 più sottocategorie

Trovati 5622 prodotti di "Apoptosi"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • EGFR-IN-47


    <p>EGFR-IN-47: strong oral EGFRL858R/T790M/C797S blocker, induces cell death; promising for NSCLC research. IC50: 0.01 μM.</p>
    Formula:C29H35N7
    Colore e forma:Solid
    Peso molecolare:481.64
  • Anticancer agent 45


    <p>Anticancer agent 46, potent and selective, induces apoptosis, is cytotoxic to cancer cells, with low toxicity to human lymphocytes.</p>
    Formula:C22H14ClN3O6S2
    Colore e forma:Solid
    Peso molecolare:515.95
  • HDAC-IN-9


    <p>HDAC-IN-9, a dual tubulin/HDAC inhibitor, impedes A549 cell invasion/migration and shows strong anti-tumor/angiogenic effects.</p>
    Formula:C33H38N2O4
    Colore e forma:Solid
    Peso molecolare:526.67
  • D-Cl-amidine hydrochloride


    <p>D-Cl-amidine hydrochloride is a potent and highly selective inhibitor of PAD1. It exhibits excellent tolerance and does not induce significant toxicity [1].</p>
    Formula:C14H20Cl2N4O2
    Colore e forma:Solid
    Peso molecolare:347.24
  • Anticancer agent 53

    CAS:
    <p>Anticancer agent 53 exhibits potent in vitro cytotoxicity, triggers apoptosis, halts S/G2/M cycle, and has antitumor effects without toxicity.</p>
    Formula:C31H25FN4O6S
    Colore e forma:Solid
    Peso molecolare:600.62
  • Flizasertib

    CAS:
    <p>Flizasertib is a serine/threonine kinase inhibitor that acts by inhibiting RIPK1, which has anti-inflammatory and therapeutic effects on immune disorders.</p>
    Formula:C15H14FN3O
    Purezza:99.39% - 99.57%
    Colore e forma:Solid
    Peso molecolare:271.29
  • DHU-Se1


    <p>DHU-Se1: potent anti-inflammatory, releases reactive selenium from macrophages, inhibits iNOS/TNF-α, blocks M0 to M1 polarization.</p>
    Formula:C23H23N3OSSe
    Colore e forma:Solid
    Peso molecolare:468.47
  • RWJ-56110

    CAS:
    <p>protease-activated receptor-1 (PAR1) antagonist</p>
    Formula:C41H43Cl2F2N7O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:790.73
  • JAK-2/3-IN-3


    <p>JAK-2-/3-IN-3 (ST4j) is a potent JAK2/3 inhibitor for leukemia research, with IC50s: JAK2, 13 nM; JAK3, 14.86 nM; induces apoptosis.</p>
    Formula:C13H10Cl2N4O2
    Colore e forma:Solid
    Peso molecolare:325.15
  • Ganoderic acid R

    CAS:
    <p>Ganoderic acid R: potent anticancer, induces apoptosis, cytotoxic to MDR and sensitive tumor cells.</p>
    Formula:C34H50O6
    Colore e forma:Solid
    Peso molecolare:554.76
  • Anticancer agent 65

    CAS:
    <p>Anticancer agent 65: Effective on A549 cells, IC50 1.07 μM, halts S phase, triggers apoptosis, elevates p53/p21, causes ROS and MMP collapse.</p>
    Formula:C36H63NO5
    Colore e forma:Solid
    Peso molecolare:589.89
  • CCT369260

    CAS:
    <p>CCT369260 (compound 1), an orally active inhibitor targeting B-cell lymphoma 6 (BCL6), demonstrates anti-tumor efficacy with an IC50 value of 520 nM [1].</p>
    Formula:C24H31ClF2N6O2
    Colore e forma:Solid
    Peso molecolare:508.99
  • RET-IN-11


    <p>RET-IN-11 selectively inhibits RET (IC50: 6.20 nM), promotes apoptosis, and hinders cell proliferation and migration.</p>
    Formula:C27H30FN9O
    Colore e forma:Solid
    Peso molecolare:515.59
  • ASK1-IN-7

    CAS:
    <p>ASK1-IN-7 (Compound 4c) is an ASK1 inhibitor and a derivative of the ASK1 inhibitor scaffold 5-(5-Phenyl-furan-2-ylmethylene)-2-thioxo-thiazolidin-4-one. This compound is potentially applicable in research involving ASK1 signaling pathways, including studies on cellular stress response, inflammatory response, neurodegenerative diseases, and cardiovascular diseases.</p>
    Formula:C13H8N2O2S2
    Colore e forma:Solid
    Peso molecolare:288.345
  • PARP10/15-IN-2

    CAS:
    <p>PARP10/15-IN-2 (Compound 8h) blocks PARP10/15, has IC50s: 0.15μM/0.37μM, cell-permeable, prevents apoptosis.</p>
    Formula:C15H11FN2O3
    Colore e forma:Solid
    Peso molecolare:286.26
  • Mcl-1 inhibitor 22

    CAS:
    <p>Mcl-1 inhibitor22 (Example 36) is an MCL-1 inhibitor that suppresses its anti-apoptotic function by blocking the interaction between MCL-1 and pro-apoptotic proteins. It exhibits antiproliferative activity against various cancer cell lines and can be utilized for cancer research.</p>
    Formula:C33H33ClFN3O4
    Colore e forma:Solid
    Peso molecolare:590.084
  • L-threo-Sphingosine C-18

    CAS:
    <p>L-threo-Sphingosine C-18 is a protein kinase C inhibitor.</p>
    Formula:C18H37NO2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:299.49
  • Topo I/COX-2-IN-2


    <p>Compound W10 is a dual inhibitor of Topo I (IC50: 0.90μM) and COX-2 (IC50: 2.31μM), inducing cancer cell apoptosis via mitochondria.</p>
    Formula:C24H25ClN4O
    Colore e forma:Solid
    Peso molecolare:420.93
  • FTO-IN-13

    CAS:
    <p>FTO-IN-13 (compound 8t) is a potent FTO inhibitor with antiproliferative properties. It induces apoptosis (cell apoptosis) and reduces the expression of Bcl-2 and Caspase 3 active proteins. Additionally, FTO-IN-13 lowers the expression of MYC and CEBPA genes and demonstrates anticancer activity.</p>
    Formula:C18H12Br2N2O4
    Colore e forma:Solid
    Peso molecolare:480.107
  • GI-Y2

    CAS:
    <p>GI-Y2 is a GSDMD inhibitor that suppresses macrophage pyroptosis induced by oxidized low-density lipoprotein (ox-LDL). In vivo, GI-Y2 dose-dependently reduces atherosclerotic plaques and decreases lesion size and fibrosis in the aortic root of ApoE-/- mice. GI-Y2 holds potential for research in pyroptosis and cardiovascular diseases, such as atherosclerosis.</p>
    Formula:C18H14N2O6S
    Colore e forma:Solid
    Peso molecolare:386.379